Literature DB >> 3947510

Verapamil increases the sensitivity of primary human colorectal carcinoma tissue to vincristine.

P Ince, D R Appleton, K J Finney, J P Sunter, A J Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3947510      PMCID： PMC2001478          DOI： 10.1038/bjc.1986.19

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  10 in total

Review 1.  Multidrug-resistance phenotype in Chinese hamster ovary cells.

Authors:  V Ling; N Kartner; T Sudo; L Siminovitch; J R Riordan
Journal:  Cancer Treat Rep       Date:  1983-10

2.  Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.

Authors:  W T Beck; M C Cirtain; J L Lefko
Journal:  Mol Pharmacol       Date:  1983-11       Impact factor: 4.436

3.  Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug.

Authors:  T Tsuruo; H Iida; K Naganuma; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

4.  Identification and characterization of a plasma membrane phosphoprotein which is present in Chinese hamster lung cells resistant to adriamycin.

Authors:  D Garman; L Albers; M S Center
Journal:  Biochem Pharmacol       Date:  1983-12-01       Impact factor: 5.858

5.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

6.  Human colorectal tumours in short-term organ culture. A stathmokinetic study.

Authors:  C J Pritchett; P V Senior; J P Sunter; A J Watson; D R Appleton; R G Wilson
Journal:  Cell Tissue Kinet       Date:  1982-09

7.  Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

8.  Morphological studies on the long-term organ culture of colonic mucosa from normal and dimethylhydrazine treated rats.

Authors:  P V Senior; J P Sunter; D R Appleton; A J Watson
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

9.  Demonstration of vincristine resistance in primary intestinal neoplasms in the rat by the 'post-metaphase index'.

Authors:  P Ince; K J Finney; D R Appleton; J P Sunter; A J Watson
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

10.  Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.

Authors:  A Ramu; R Spanier; H Rahamimoff; Z Fuks
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640
  10 in total
  7 in total

1.  Expression of verapamil hypersensitivity in multidrug-resistant cells grown as multicellular spheroids.

Authors:  M Anderson; J R Warr
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Organ culture as a model for investigating the effects of antimetabolites and nucleoside transport inhibitors on rodent colonic mucosa.

Authors:  M Moorghen; P Ince; K J Finney; A J Watson; A L Harris
Journal:  In Vitro Cell Dev Biol       Date:  1991-11

3.  Effect of verapamil on cell cycle transit and c-myc gene expression in normal and malignant murine cells.

Authors:  K R Huber; W F Schmidt; E A Thompson; A M Forsthoefel; R W Neuberg; R S Ettinger
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

4.  Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.

Authors:  L Gossner; H Wittke; A Warzecha; R Sroka; H Ernst; M Meier; C Ell
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

5.  Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells.

Authors:  Lu Zhao; Yue Zhao; Bettina Schwarz; Josef Mysliwietz; Roland Hartig; Peter Camaj; Qi Bao; Karl-Walter Jauch; Makus Guba; Joachim Walter Ellwart; Peter Jon Nelson; Christiane Josephine Bruns
Journal:  Int J Oncol       Date:  2016-05-10       Impact factor: 5.650

6.  Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer.

Authors:  Yang Dong; Hongze Liao; Jian Yu; Hao Fu; Ke Gong; Qi Wang; Yourong Duan
Journal:  J Nanobiotechnology       Date:  2019-12-23       Impact factor: 10.435

7.  Verapamil sensitizes normal and neoplastic rodent intestinal tissues to the stathmokinetic effect of vincristine in vivo.

Authors:  P Ince; D R Appleton; K J Finney; M Moorghen; J P Sunter; A J Watson
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.